Reading a 15-metric scorecard without letting the average hide the one score that matters, using a reverse DCF as a veto, and recognising the businesses whose quality is already fully known.
1. Score a business on fixed metrics — then read the sub-scores, never the average
The repeatable method
- Run every candidate through the same fifteen headings — business model, management, competitive advantage, industry, risks, balance sheet, capital intensity, capital allocation, profitability, stock-based compensation, historical growth, outlook, valuation, owner's-earnings evolution, historical value creation — and score each out of ten with the evidence written beside it.
- Compute the total as the plain average, but treat it as a filing label rather than a verdict.
- Read the distribution. A respectable total can hide a catastrophic single score, because averaging is precisely what dilutes it.
- Nominate in advance which sub-scores are vetoes rather than contributors. Valuation and main risks are the natural candidates: no amount of business quality repairs an unpayable price or an unacceptable single point of failure.
- Keep the failing evidence in the sheet rather than arguing it away, so the next reader sees the same trade-off.
Here: HEI scores 7.8/10 overall — but thirteen of fifteen metrics are 7 or better (historical value creation 10/10, capability management 9.5, business model / capital intensity / capital allocation / historical growth / outlook all 9), while valuation is 2/10 and main risks 5/10. The decision follows the two low scores, not the 7.8.
Watch for
- Scoring drift — the same analyst grading a favourite business half a point higher across every heading.
- Metrics that double-count one strength (capital intensity and capital allocation both rewarding the same capital-light model).
2. Use a reverse DCF as a veto: compare the implied growth with the delivered growth
The repeatable method
- Instead of forecasting cash flows, solve backwards: at today's price and a required return, what annual free-cash-flow growth rate is being assumed?
- Put that number beside the company's own realised growth over five and ten years.
- If the implied rate exceeds the best period the business has ever delivered, the price is not a forecast — it is a bet on an improvement nobody has demonstrated.
- Say so numerically in the write-up, so the pass is falsifiable and the level that would change it is implicit.
- Keep the name on a follow list with the yield as the tracking metric, and revisit when the price moves rather than when the story does.
Here: the reverse DCF requires 21.4% annual FCF growth, against owner's earnings that grew 14.3% over five years and 8.7% over ten. Forward PE 53.7x versus a 46.9x ten-year average (57.3x versus 50.3x on the Fiscal.ai onepager), FCF yield 1.8%. Verdict: "Valuation looks stretched… This leaves little margin of safety."
Watch for
- A reverse DCF whose required return assumption is doing the work; state it explicitly (10% here, per this source's standard).
- Serial acquirers whose historical growth was acquisition-funded — the implied rate must be achievable with the same deal cadence and the same balance sheet.
3. Treat "quality everyone already knows about" as a structural obstacle, not a compliment
The repeatable method
- Ask whether your view of the business differs from consensus at all. If it does not, the only remaining source of return is the price.
- Check whether the shares have ever traded at a discount to their own history. A name that never de-rates offers no entry point, only a queue.
- Distinguish this from a de-rated compounder, where fear has created a gap between quality and price — that is the setup this source normally buys.
- Decide explicitly which of the two you are looking at before doing any more work, because the second half of the analysis differs completely.
Here: "HEICO's quality is well recognized, so the stock rarely trades at a discount." Contrast with the same publication's February-April 2026 buying — Constellation, Fortinet, MSCI, S&P Global, FICO — all excellent businesses that had de-rated 25-50% on AI fear.
Watch for
- Waiting forever for a de-rating that a genuinely scarce asset never delivers; a follow list needs a review cadence and a price, not just patience.
- Confusing a fall from an extreme multiple with cheapness — 53x down to 40x is still not a discount.
4. Look for moats made of certification, where the customer also saves money
The repeatable method
- Identify industries where a third party must approve a product before it can be sold, and where approval takes years and money rather than cleverness.
- Find the companies that have accumulated many approvals. Each one is a small permanent monopoly, and the stock of them compounds.
- Confirm the customer is also better off — an approval-based moat that raises the customer's cost invites regulatory or commercial attack; one that lowers it is stable.
- Check that demand is tied to usage rather than to new-unit sales, so revenue tracks the installed base's activity instead of the capital cycle.
- Verify the breadth of the catalogue, since a single approved part is a niche and twenty thousand is an infrastructure position.
Here: HEI — parts approved through the FAA's PMA route, "cheaper than the originals yet equally reliable," with "strict FAA rules creat[ing] a high barrier to entry," 20,000+ approved parts, and revenue driven by flight hours: "every time an aircraft flies, parts wear out and eventually need to be replaced."
Watch for
- Contractual end-runs around the regulation — the risk section names exactly this: "airlines may be restricted from using PMA parts under certain contracts."
- Incumbents defending the aftermarket with bundled service agreements that make the cheaper part irrelevant.
5. Judge a serial acquirer's ratios against its model, and know which thresholds it will always fail
The repeatable method
- Before applying your standard thresholds, ask which of them the business model mechanically violates.
- For an acquisitive company, goodwill as a share of assets will be high and reported ROIC will be depressed, because every purchase price sits in the denominator.
- Substitute measures that strip the acquisition accounting — return on tangible assets, return on capital employed, FCF versus net income — and judge on those.
- Then re-impose the thresholds that still bind: interest coverage, net debt versus free cash flow, and stock-based compensation.
- Record the failures rather than adjusting them away, so the scorecard remains comparable across business models.
Here: goodwill/assets 44.4% against this source's usual <20% guideline, and ROIC 11.2% against its usual >15% — yet return on tangible assets is 18.7%, ROE 16.6% and five-year FCF/net income 110.7%, with interest coverage 9.0x and net debt/FCF 2.7x. Balance sheet still only scores 7/10; the failures are logged, not explained away.
Watch for
- Goodwill impairments, which convert a tolerated ratio into a realised loss.
- An acquirer whose organic growth is invisible because every reported number is a blend; ask for the same-store figure.
6. Price key-person and single-event risk as its own score
The repeatable method
- Give risk a dedicated line on the scorecard rather than treating it as a discount to the other lines.
- Name the specific dependency — a family, a founder, a regulator, one customer — and ask what happens the day it is removed.
- Add the tail event the business model makes possible but rare: for a parts maker, a failure in service; for a lender, a credit event; for a data business, a breach.
- Score it honestly even when the score is embarrassing next to the rest, and let it constrain position size or the conviction tier rather than the buy/sell decision alone.
Here: main risks scored 5/10 — "too dependant on the Mendelsons" (the family has led the company since 1990 and owns ~16.6%) and "a failure of a part in a plane could cause massive reputation damage." The same instinct produced the governance cap on Kelly Partners in April.
Watch for
- Succession that is announced but untested; the risk score should not fall until the handover has actually happened.
- Reputational tails that are uninsurable — a 5/10 here is not a number you can hedge.
7. Take in outside research, but keep the verdict in-house
The repeatable method
- Accept long-form work from other analysts as raw material — it saves the fact-gathering, which is the expensive part.
- Re-run your own scorecard and your own valuation on it before forming a view, using the same headings you use for everything else.
- Publish the summary, the onepager and the score alongside the source document, so a reader can see what was adopted and what was assessed independently.
- State the decision in your own words, and make it possible for the decision to contradict the contributed case.
Here: the 186-page case is Alexander's (Slow Compounding), shared and credited; the 15-metric Quality Score and the "are we buying?" verdict are Compounding Quality's own — and the verdict is no. Same pattern as the Brookfield deep-dive by Jochen Vandenbergh and the TJ Terwilliger issue three days earlier.
Watch for
- Adopting the contributor's conclusion along with their facts; the length of a document is not evidence for its verdict.
- Undisclosed positions held by the contributing analyst — worth asking before leaning on the work.
Methods distilled from the archived Compounding Quality post for personal study. Not investment advice.